The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...

The FDA approved its short-acting insulin, Fiasp (insulin aspart injection) in September, and its long-acting insulin Tresiba (insulin degludec) got US approval late last year. [caption id ...

For information about short-acting insulin and other types of insulin ... Having a high level of blood sugar over a long period of time can cause serious problems, including kidney disease ...

The world will probably look a bit different a decade from now than it does today, so long-term investors need to try to zoom ... treated diabetes and obesity since it pioneered slow-acting insulin in ...

It turns out that the anti-obesity space isn't growing as fast as Eli Lilly or analysts anticipated, resulting in ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Ironwood Pharmaceuticals, Inc. today announced it will host its fourth quarter and full year 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, February 27, 2025.

Enter oats. These convenient, whole grains are an easy way to up the fiber ante in your smoothie. Plus, they’re packed with ...

While still robust, CSL half-year results last Weds revealed impact of an “alarming” fall off in 'flu vax rates, especially ...

Novo Nordisk A/S NVO reported fourth-quarter 2024 earnings of 91 cents per American Depositary Receipt (ADR), which beat the ...

Can you really eat or drink your way to better sleep? It would certainly be a simple solution for the one in five estimated ...

“When blood sugar is raised quickly [after eating sugar and white carbs], your body reacts by releasing insulin, and the ...